Setting a stage: Inflammation during preeclampsia and postpartum

Area of Science:

• Obstetrics and Gynecology
• Immunology
• Maternal-Fetal Medicine

Background:

• Preeclampsia (PE) is a major global cause of maternal and fetal mortality.
• Inflammation and immune system dysregulation are central to PE pathophysiology.
• PE-associated inflammation can persist into the postpartum period.

Purpose of the Study:

• To review recent research on inflammation in preeclampsia.
• To discuss postpartum inflammation in women with a history of PE.
• To explore the link between COVID-19 infection in pregnancy and increased PE incidence.

Main Methods:

• Literature review of recent studies on inflammation in PE.
• Analysis of research on postpartum inflammatory profiles.
• Examination of data linking COVID-19 pregnancy complications with PE.

Main Results:

• Inappropriate inflammatory responses characterize preeclampsia.
• Persistent inflammation is observed postpartum in women affected by PE.
• COVID-19 infection during pregnancy is associated with a higher incidence of PE.

Conclusions:

• Understanding PE inflammation is crucial for maternal and fetal health.
• Postpartum monitoring for inflammation may be necessary for women with PE history.
• The impact of COVID-19 on PE incidence warrants further investigation.